DYRK1A and non-small cell lung carcinoma: As expected, we observed synergistic cytotoxic effects when the DYRK1A inhibitor, harmine, was combined with either ABT-737 or ABT-199 in NSCLC cells, with mean CI values below 0.9 (Figure 4A).